Description
Used in the treatment of:
- HER2-positive early or metastatic breast cancer
- HER2-positive metastatic gastric cancer
Trastuzumab is a humanized monoclonal antibody that targets HER2 receptors, inhibiting tumor cell proliferation and enhancing immune-mediated cytotoxicity.



